MA52937A - Composés inhibiteurs d'oga - Google Patents

Composés inhibiteurs d'oga

Info

Publication number
MA52937A
MA52937A MA052937A MA52937A MA52937A MA 52937 A MA52937 A MA 52937A MA 052937 A MA052937 A MA 052937A MA 52937 A MA52937 A MA 52937A MA 52937 A MA52937 A MA 52937A
Authority
MA
Morocco
Prior art keywords
inhibitor compounds
oga inhibitor
oga
compounds
inhibitor
Prior art date
Application number
MA052937A
Other languages
English (en)
Inventor
José Manuel Bartolomé-Nebreda
Susana Conde-Ceide
Lucas Olivares Ana Isabel De
Francisca Delgado-Jiménez
Andrés Avelino Trabanco-Suárez
Ramiro Juan Antonio Vega
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of MA52937A publication Critical patent/MA52937A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/052—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/056—Ortho-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MA052937A 2018-06-20 2019-06-20 Composés inhibiteurs d'oga MA52937A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP18382449 2018-06-20

Publications (1)

Publication Number Publication Date
MA52937A true MA52937A (fr) 2021-04-28

Family

ID=62784076

Family Applications (1)

Application Number Title Priority Date Filing Date
MA052937A MA52937A (fr) 2018-06-20 2019-06-20 Composés inhibiteurs d'oga

Country Status (9)

Country Link
US (1) US20210122763A1 (fr)
EP (1) EP3810612A1 (fr)
JP (1) JP2021527663A (fr)
CN (1) CN112292381A (fr)
AU (1) AU2019289971A1 (fr)
CA (1) CA3103758A1 (fr)
MA (1) MA52937A (fr)
TW (1) TW202016118A (fr)
WO (1) WO2019243530A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3045745A1 (fr) * 2017-02-27 2018-08-30 Janssen Pharmaceutica Nv Derives de [1,2,4]-triazolo [1,5-a]-pyrimidinyle substitues par de la piperidine, de la morpholine ou de la piperazine utilises en tant qu'inhibiteurs d'oga
CN113368243A (zh) * 2021-06-07 2021-09-10 中国人民解放军军事科学院军事医学研究院 髓母细胞瘤的治疗靶点及其应用
KR20260002803A (ko) * 2023-05-02 2026-01-06 지위, 엘엘씨 치료적 사용을 위한 암브록솔의 변형된 형태

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107108601B (zh) * 2014-08-28 2021-08-20 阿森纽荣股份公司 糖苷酶抑制剂
WO2017144633A1 (fr) * 2016-02-25 2017-08-31 Asceneuron S. A. Inhibiteurs de glycosidases
JP2020503298A (ja) * 2016-12-16 2020-01-30 ヤンセン ファーマシューティカ エヌ．ベー． 単環式ｏｇａ阻害剤化合物
WO2019037860A1 (fr) * 2017-08-24 2019-02-28 Asceneuron S.A. Inhibiteurs linéaires de la glycosidase

Also Published As

Publication number Publication date
US20210122763A1 (en) 2021-04-29
CN112292381A (zh) 2021-01-29
TW202016118A (zh) 2020-05-01
CA3103758A1 (fr) 2019-12-26
JP2021527663A (ja) 2021-10-14
AU2019289971A1 (en) 2020-12-17
WO2019243530A1 (fr) 2019-12-26
EP3810612A1 (fr) 2021-04-28

Similar Documents

Publication Publication Date Title
MA52939A (fr) Composés inhibiteurs d'oga
MA52942A (fr) Composés inhibiteurs d'oga
MA47420A (fr) Composés inhibiteurs d'oga
IL292753A (en) Compounds
MA47575A (fr) Composés inhibiteurs d'oga monocyclique
EP3836923A4 (fr) Composés pyrrolo-dipyridine
MA47576A (fr) Composés inhibiteurs d'oga bicyclique
EP3941898C0 (fr) Composés fongicides
MA52948A (fr) Composés
EP3737672A4 (fr) Composés benzamide
IL286833A (en) Compositions containing brazzein
MA51669A (fr) Composés
EP3906029A4 (fr) Inhibiteurs de l'interaction ménine-mll
DK4083038T3 (da) Pyridazinylthiazolcarboxamidforbindelse
EP3464275A4 (fr) Composés inhibiteurs de l'egfr
MA53003A (fr) Composés
MA52004A (fr) Inhibiteurs d'o-glycoprotéine-2-acétamido-2-désoxy-3-d-glycopyranosidase
MA49006A (fr) Inhibiteurs d'ip6k
MA54521A (fr) Dérivés d'oxopyridine substitués
EP4077318A4 (fr) Composés
MA52946A (fr) Composés
EP3833342A4 (fr) Composés d'imidazotétrazine
EP3808747A4 (fr) Composé d'imidazopyridinone
MA53648A (fr) Inhibiteurs d'o-glycoprotéine-2-acétamido-2-désoxy-3-d-glucopyranosidase
EP4003986A4 (fr) Composés inhibiteurs